Track 22: Cell Therapy in Pulmonology
Depending on the level of inflation, the human lung's surface area ranges from 35 to 100 m2, enabling an efficient exchange of the oxygen required for oxidative metabolism.Toxins in the air as well as microorganisms and their by-products are exposed to this contact area. Despite these on-going assaults, the lung in healthy people is able to govern tissue plasticity required for injury repair as well as immunological reactions (upregulation and down-modulation of responses), allowing the maintenance of homeostasis. Although the causes of many lung disorders are yet unknown, their complicated pathophysiology is frequently linked to immune response dysregulation (such as chronic inflammation in chronic pulmonary disease) and abnormal lung tissue repair mechanisms (such as idiopathic pulmonary fibrosis).
Related Conference of Track 22: Cell Therapy in Pulmonology
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Track 22: Cell Therapy in Pulmonology Conference Speakers
Recommended Sessions
- Track 10: Cellular Therapies
- Track 11: Advanced Gene Therapeutics
- Track 12: CAR T-cell therapy
- Track 13: Cancer Therapies
- Track 14: Nano-Therapy
- Track 15: Human Gene Therapy
- Track 16: Diabetes Gene Therapy
- Track 17: Molecular Epigenetics
- Track 18: Genetic Vaccines
- Track 19: Clinical Trials and Research in Cell and Gene Therapies
- Track 1: Cell Science and Stem Cell Research
- Track 20: Skin cell therapy
- Track 21: HIV gene therapy
- Track 22: Cell Therapy in Pulmonology
- Track 2: Stem Cell Therapies
- Track 3: Cell Culture and Bioprocessing
- Track 4: Viral gene therapy
- Track 5: Stem Cell in Drug Development
- Track 6: Nanotechnology in Stem Cell
- Track 7: Stem Cell in Cardiovascular Disease
- Track 8: Novel Stem Cell Therapy
- Track 9: Stem cell engineering
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
